MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 29, 2005; DOI: 10.1124/mol.105.017368


0026-895X/06/6903-960-967$20.00
Mol Pharmacol 69:960-967, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.017368v1
69/3/960    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, C.-Y.
Right arrow Articles by Lin, W.-W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, C.-Y.
Right arrow Articles by Lin, W.-W.

The Role of Rho-Associated Kinase in Differential Regulation by Statins of Interleukin-1beta- and Lipopolysaccharide-Mediated Nuclear Factor {kappa}B Activation and Inducible Nitric-Oxide Synthase Gene Expression in Vascular Smooth Muscle Cells

Chun-Yu Wei, Kuo-Chin Huang, Yin-Hsiang Chou, Pe-Fang Hsieh, Kuei-Hui Lin, and Wan-Wan Lin

Departments of Pharmacology (C.-Y.W., Y.-H.C., P.-F.H., K.-H.L., W.-W.L.) and Family Medicine (K.-C.H.), National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan

An optimal level of NO has protective effects in atherosclerosis, whereas large amounts contribute to septic shock. To study how statins, the potent inhibitors of cholesterol synthesis, regulate NO in the vascular wall, we determined their effects on interleukin-1beta (IL-1beta)- and lipopolysaccharide (LPS)-induced NO production in aortic vascular smooth muscle cells (VSMCs). Compared with the large amounts of NO and inducible NO synthase (iNOS) protein expression induced by LPS, the responses of IL-1beta were modest. Various statins were found to inhibit LPS-induced iNOS expression and NO production, although they potentiated IL-1beta responses. In addition, fluvastatin increased IL-1beta-induced p65 nuclear translocation and nuclear factor {kappa}B (NF-{kappa}B) activity, although it inhibited those induced by LPS. To address the role of small G proteins in statin's actions, farnesyl transferase inhibitors [{alpha}-hydroxyfarne-sylphosphonic acid and (2S)-2-[[(2S)-2-[(2S,3S)-2-[(2R)-2-amino-3-mercaptopropyl]amino]-3-methylpentyl]oxy]-1-oxo-3-phenylpropyl]amino]-4-(methylsulfonyl)-butanoic acid 1-methylethyl ester (L-744382)], Rac inhibitor (NSC23766), and Rho-associated kinase (ROCK) inhibitor [N-(4-pyridyl)-4-(1-aminoethyl)cyclohexanecarboxamide dihydrochloride (Y-27632)] were used. We found that Y-27632 potentiated IL-1beta-induced iNOS expression, p65 nuclear translocation, I{kappa}B kinase (IKK), and NF-{kappa}B activation, whereas it had minimal effects on LPS-induced responses. In contrast, farnesyl transferase inhibitors blocked iNOS protein expression induced by LPS and IL-1beta, whereas NSC23766 had no effect. Further studies showed that LPS down-regulated Rho and ROCK activity, whereas IL-1beta increased them, suggesting a negative role of Rho and ROCK signaling, which is regulated in contrary manners by IL-1beta and LPS, in IKK/NF-{kappa}B activation. Through abrogating this negative signaling, statins differentially regulate iNOS expression induced by LPS and IL-1beta in VSMCs. These differential actions of statins on iNOS gene regulation might provide an additional explanation for the pleiotropic beneficial effects of statins.


Received July 27, 2005; accepted November 29, 2005

Address correspondence to: Dr. Wan-Wan Lin, Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan. E-mail: wwl{at}ha.mc.ntu.edu.tw




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
S. Doublier, C. Riganti, C. Voena, C. Costamagna, E. Aldieri, G. Pescarmona, D. Ghigo, and A. Bosia
RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells
Mol. Cancer Res., October 1, 2008; 6(10): 1607 - 1620.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Mira, B. Leon, D. F. Barber, S. Jimenez-Baranda, I. Goya, L. Almonacid, G. Marquez, A. Zaballos, C. Martinez-A., J. V. Stein, et al.
Statins Induce Regulatory T Cell Recruitment via a CCL1 Dependent Pathway
J. Immunol., September 1, 2008; 181(5): 3524 - 3534.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Machida, Y. Hamaya, S. Izumi, Y. Hamaya, K. Iizuka, Y. Igarashi, M. Minami, R. Levi, and M. Hirafuji
Sphingosine 1-Phosphate Inhibits Nitric Oxide Production Induced by Interleukin-1{beta} in Rat Vascular Smooth Muscle Cells
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 200 - 209.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. W. Tew, E. L. Lorimer, T. J. Berg, H. Zhi, R. Li, and C. L. Williams
SmgGDS Regulates Cell Proliferation, Migration, and NF-{kappa}B Transcriptional Activity in Non-small Cell Lung Carcinoma
J. Biol. Chem., January 11, 2008; 283(2): 963 - 976.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Schmidt, T. H. Westhoff, P. Krauser, W. Zidek, and M. van der Giet
The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 65 - 71.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Chauhan, S. Hahn, S. Gartner, C. A. Pardo, S. K. Netesan, J. McArthur, and A. Nath
Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins
FASEB J, March 1, 2007; 21(3): 777 - 789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Jin, R. M. Ray, and L. R. Johnson
Rac1 mediates intestinal epithelial cell apoptosis via JNK
Am J Physiol Gastrointest Liver Physiol, December 1, 2006; 291(6): G1137 - G1147.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics